Market Overview:
The global xylazine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for xylazine in veterinary applications, increasing awareness about animal health and growing demand for meat and dairy products. However, the high cost of xylazine may restrain the growth of this market to some extent. On the basis of type, the global xylazine market is segmented into powder and crystal form. The powder form is expected to dominate the global market during the forecast period owing to its easy handling and storage properties as compared to crystal form.
Product Definition:
Xylazine is a sedative used for horses and cattle. It is also given to humans as a preoperative medication to produce relaxation and relieve anxiety.
Powder:
Powder is a fine, white crystalline powder and is soluble in water. It has an odor similar to that of sugar or corn starch. It is produced by the hydrolysis of polymers such as xylan and mannan oligosaccharides with alkali catalysts.
Crystal:
Crystal is a crystalline solid and has a sweet taste. It is soluble in water, ethanol, and diethyl ether but insoluble in aliphatic hydrocarbons. Crystal xylazine (CXP)is an injectable form of the veterinary anesthetic agent that is most commonly used for intramuscular or intravenous injection to provide anesthesia during surgical procedures on animals.
Application Insights:
Based on the application, the global xylazine market is segmented into anesthetic, tranquilizer and other drugs. The anesthetic segment dominated the overall market in terms of revenue share in 2017. This high share is attributable to rising demand for surgical procedures across various end-use industries such as hospitals and clinics. In addition, increasing R&D investments by key industry players are expected to boost product innovation over the coming years which would further propel demand from anesthetic applications.
The tranquilizer segment held a significant revenue share of 19% in 2017 owing to growing use of xylazine as a sedative for animals including horses and dogs among others at pet stores or kennels where they are kept overnight or during holidays when there are visitors staying at hotels or motels near these places of business then this drug can be used safely without any side effects it also has uses as a general anxiety medication for humans under medical supervision therefore contributing towards its popularity within this sector.
Regional Analysis:
North America dominated the global xylazine market in 2017. The growth can be attributed to increasing demand for general anesthesia and sedation in veterinary surgeries across the U.S., coupled with rising pet ownership, which is fueling product demand. In addition, high adoption of pets among millennials is expected to fuel market growth over the forecast period.
Asia Pacific is expected to witness fastest growth during the forecast period owing to rising number of livestock farming operations across countries such as China and India, thereby driving product consumption for sedation purposes. Furthermore, growing awareness about animal health & well-being among farmers will drive regional demand further.
Latin America has been witnessing steady economic development along with a rise in disposable income since 2010; however, it remains one of the most underdeveloped regions globally due to political instability.
Growth Factors:
- Increasing demand for Xylazine in veterinary applications owing to its various benefits such as analgesia, muscle relaxation, and sedation.
- Rising awareness about the benefits of Xylazine among livestock farmers and veterinarians is expected to propel the growth of the market over the forecast period.
- Growing research and development activities for new applications of Xylazine is anticipated to create new opportunities for market growth in the coming years.
- Increasing investments by key players in manufacturing facilities is likely to boost production capacity and meet rising demand from consumers globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Xylazine Market Research Report
By Type
Powder, Crystal
By Application
Anesthetic, Tranquilizer
By Companies
Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Bayer AG, Elanco, Ceva Sante Animale S.A., Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Covetrus, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Xylazine Market Report Segments:
The global Xylazine market is segmented on the basis of:
Types
Powder, Crystal
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anesthetic, Tranquilizer
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis Inc.
- Boehringer Ingelheim Animal Health
- Merck Animal Health
- Bayer AG
- Elanco
- Ceva Sante Animale S.A.
- Virbac SA
- Vetoquinol SA
- IDEXX Laboratories, Inc.
- Covetrus, Inc.
Highlights of The Xylazine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Crystal
- By Application:
- Anesthetic
- Tranquilizer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Xylazine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Xylazine is a medication used to treat pain. It is also used to sedate animals before surgery or during transport.
Some of the major players in the xylazine market are Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Bayer AG, Elanco, Ceva Sante Animale S.A., Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Covetrus, Inc..
The xylazine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Xylazine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Xylazine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Xylazine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Xylazine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Xylazine Market Size & Forecast, 2018-2028
4.5.1 Xylazine Market Size and Y-o-Y Growth
4.5.2 Xylazine Market Absolute $ Opportunity
Chapter 5 Global Xylazine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Xylazine Market Size Forecast by Type
5.2.1 Powder
5.2.2 Crystal
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Xylazine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Xylazine Market Size Forecast by Applications
6.2.1 Anesthetic
6.2.2 Tranquilizer
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Xylazine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Xylazine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Xylazine Analysis and Forecast
9.1 Introduction
9.2 North America Xylazine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Xylazine Market Size Forecast by Type
9.6.1 Powder
9.6.2 Crystal
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Xylazine Market Size Forecast by Applications
9.10.1 Anesthetic
9.10.2 Tranquilizer
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Xylazine Analysis and Forecast
10.1 Introduction
10.2 Europe Xylazine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Xylazine Market Size Forecast by Type
10.6.1 Powder
10.6.2 Crystal
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Xylazine Market Size Forecast by Applications
10.10.1 Anesthetic
10.10.2 Tranquilizer
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Xylazine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Xylazine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Xylazine Market Size Forecast by Type
11.6.1 Powder
11.6.2 Crystal
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Xylazine Market Size Forecast by Applications
11.10.1 Anesthetic
11.10.2 Tranquilizer
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Xylazine Analysis and Forecast
12.1 Introduction
12.2 Latin America Xylazine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Xylazine Market Size Forecast by Type
12.6.1 Powder
12.6.2 Crystal
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Xylazine Market Size Forecast by Applications
12.10.1 Anesthetic
12.10.2 Tranquilizer
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Xylazine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Xylazine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Xylazine Market Size Forecast by Type
13.6.1 Powder
13.6.2 Crystal
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Xylazine Market Size Forecast by Applications
13.10.1 Anesthetic
13.10.2 Tranquilizer
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Xylazine Market: Competitive Dashboard
14.2 Global Xylazine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis Inc.
14.3.2 Boehringer Ingelheim Animal Health
14.3.3 Merck Animal Health
14.3.4 Bayer AG
14.3.5 Elanco
14.3.6 Ceva Sante Animale S.A.
14.3.7 Virbac SA
14.3.8 Vetoquinol SA
14.3.9 IDEXX Laboratories, Inc.
14.3.10 Covetrus, Inc.
